Lobo CS et al., 2022-03-19: Laboratory study showing methylene blue plus light can disinfect SARS-CoV-2 in clinical samples. It is in vitro photodynamic inactivation, not evidence that methylene blue treats a viral infection in a person.
Methylene blue (MB) has been in clinical use for a century and proved especially useful as a photosensitizer for photodynamic disinfection (PDI).
Lobo CS et al., 2022-03-19: Laboratory study showing methylene blue plus light can disinfect SARS-CoV-2 in clinical samples. It is in vitro photodynamic inactivation, not evidence that methylene blue treats a viral infection in a person. Study type: in vitro photodynamic inactivation of clinical samples. N=clinical samples (number not in abstract). Country: Portugal (Coimbra). Dose: methylene blue formulation plus light; parameters not in abstract (see paper). Comparator: untreated samples. COI: not stated in record. The virology record supports only light-activated, laboratory inactivation. Study type: lab.
